Pharmaceutical Continuous Manufacturing Market Thumbnail Image

2019

Pharmaceutical Continuous Manufacturing Market

Pharmaceutical Continuous Manufacturing Market Size, Share, Competitive Landscape and Trend Analysis Report by Product (Integrated Continuous Systems, Semicontinuous Systems, and Control & Software), Application (Final Drug Product Manufacturing and API Manufacturing), and End User (Pharmaceutical Companies, Contract Manufacturing Organizations, and Others): Global Opportunity Analysis and Industry Forecast, 2019-2026

Select an option
Author's: Sagar Mukhekar | Roshan Deshmukh
Publish Date:

Get Sample to Email

Pharmaceutical Continuous Manufacturing Market Outlook - 2026

The global pharmaceutical continuous manufacturing market was valued at $393 million in 2018, and is projected to reach $855 million by 2026, registering a CAGR of 10.2% from 2019 to 2026. 

Continuous manufacturing is an advanced manufacturing approach with the potential to improve quality and consistency of medications with lower cost. This production line is operated in a continuous flow, with end-to-end integration of manufacturing processes. The pharmaceutical continuous manufacturing market is expected to witness significant growth during the forecast period, due to technological advancements in continuous manufacturing systems and support by the regulatory authorities for adoption of continuous manufacturing systems. However, higher cost of pharmaceutical continuous manufacturing systems impedes the pharmaceutical continuous manufacturing market growth. On the contrary, pharmaceutical manufacturing systems reduce fluctuation in the production, improve yields, lower cost of operation & equipment, which are anticipated to offer remunerative opportunities for market expansion. Recently, in 2019, Caperion launched a next-generation of high accuracy vibratory feeding technology with higher accuracy and quicker product changeover. 

Pharmaceutical Continuous Manufacturing Market

Global Pharmaceutical Continuous Manufacturing Market Segmentation 

The global pharmaceutical continuous manufacturing market is segmented into product, application, end user, and region. Depending on product, the market is classified into integrated continuous systems, semicontinuous systems, and control & software. The applications covered in the study covered include final drug product manufacturing and API manufacturing. On the basis of end user, the market is categorized into pharmaceutical companies, contract manufacturing organizations, and others. Region wise, the market is studied across North America (U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, and rest of Europe), Asia-Pacific (China, Japan, India, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA). 

Segment review 

Depending on product, the integrated continuous systems segment hold the largest pharmaceutical continuous manufacturing market share in 2018, and is anticipated to exhibit significant growth during the forecast period. This is attributed to increase in adoption of integrated continuous manufacturing (ICM) process and availability of ICM systems. 

Pharmaceutical Continuous Manufacturing Market
By Product Type
Your browser does not support the canvas element.

Integrated Continuous Systems is projected as one of the most lucrative segment.

Depending on application, the final drug product manufacturing segment presently acts as the major revenue generator, and is anticipated to experience significant growth during the forecast period. Rise in number of pharmaceutical companies, technological advancements in continuous manufacturing systems, and rise in demand for pharmaceutical drugs are key drivers of this market. However, API is anticipated to exhibit fastest growth during the forecast period, due to increase in number of R&D activities to develop API with continuous manufacturing system. Furthermore, increase in number of approved drugs produced by continuous processes drives the market growth. For instance, Orkambi by Vertex, Prezista by Janssen, Verzenio by Eli Lilly and Company, and Symdeko by Vertex are produced by continuous manufacturing processes.  

Pharmaceutical Continuous Manufacturing Market
By Application
Your browser does not support the canvas element.

Final Drug Product Manufacturing holds a dominant position in 2018 and would continue to maintain the lead over the forecast period.

Snapshot of Asia-Pacific pharmaceutical continuous manufacturing market 

Asia-Pacific presents lucrative opportunities for the key players operating in the pharmaceutical continuous manufacturing market, due to increase in awareness about advanced pharmaceutical continuous manufacturing systems, rise number of pharmaceutical companies, and increase in demand for continuous manufacturing systems. However, higher cost of pharmaceutical continuous manufacturing systems may hamper the market growth in Asia-Pacific. 

Pharmaceutical Continuous Manufacturing Market
By Geography
2026
North America 
Europe
Asia-Pacific
LAMEA

Asia-Pacific region would exhibit the highest CAGR of 11.5% during 2019-2026.

The key players profiled in this report include Bosch Packaging Technology, Coperion GmbH, GEA Group AG, Gebrüder Lödige Maschinenbau GmbH, Glatt GmbH, Hosokawa Micron Corporation, Korsch AG, L.B. Bohle Maschinen + Verfahren GmbH, Munson Machinery Company, Inc., and Thermo Fisher Scientific Inc. 

Key Benefits for Pharmaceutical Continuous Manufacturing Market:

  • The study provides an in-depth analysis of the pharmaceutical continuous manufacturing market size along with the current trends and future estimations to elucidate the imminent investment pockets.
  • It provides pharmaceutical continuous manufacturing market analysis from 2018 to 2026, which is expected to enable the stakeholders to capitalize on the prevailing opportunities in the market.
  • A comprehensive analysis of four major regions is provided to determine the prevailing opportunities.
  • The profiles and growth strategies of key players are thoroughly analyzed to understand the competitive outlook and global pharmaceutical continuous manufacturing market growth.

Pharmaceutical Continuous Manufacturing Market Report Highlights

Aspects Details
Pharmaceutical Continuous Manufacturing Market By PRODUCT
By PRODUCT
  • Integrated Continuous Systems
  • Semicontinuous Systems
  • Control & Software
Pharmaceutical Continuous Manufacturing Market By APPLICATION
By APPLICATION
  • Final Drug Product Manufacturing
  • API Manufacturing
Pharmaceutical Continuous Manufacturing Market By END USER
By END USER
  • Pharmaceutical Companies
  • Contract Manufacturing Organizations
  • Others
Pharmaceutical Continuous Manufacturing Market By Region
By Region
  • North America  (U.S, Canada, Mexico)
  • Europe  (Germany, France, UK, Italy, Rest of Europe)
  • Asia-Pacific  (Japan, China, India, Rest of Asia-Pacific)
  • LAMEA  (Brazil, South Africa, Saudi Arabia, Rest of LAMEA)
Key Market Players
Key Market Players

Thermo Fisher Scientific, Inc, Coperion GmbH, Glatt GmbH, KORSCH AG, GEBRÜDER LÖDIGE MASCHINENBAU GMBH, Hosokawa Micron Corporation, L.B. Bohle Maschinen + Verfahren GmbH, GEA Group AG, Munson Machinery Company, Inc, Robert Bosch Packaging Technology GmbH

Analyst Review

Continuous manufacturing is advanced manufacturing approach to provide pharmaceutical products with improved yield within shorter time period.   

Development of the pharmaceutical industry and improvement in productivity of pharmaceuticals with reduced costs are key factors that driving the growth of Pharmaceutical Continuous Manufacturing Market. In addition, initiatives taken by the U.S. FDA for promoting the use of pharmaceutical manufacturing systems for modernizing pharmaceutical manufacturing process and advantage over the batch manufacturing are the major factors that boost the growth of the global market. However, high cost of pharmaceutical continuous manufacturing is a key factor, which hinder the market growth.        

North America is expected to remain dominant during the forecast period due to higher adoption of pharmaceutical continuous manufacturing systems, large presence of pharmaceutical companies, availability of advanced pharmaceutical continuous manufacturing systems, and supportive government policies for adoption of continuous manufacturing. In addition, Asia-Pacific and LAMEA are expected to offer lucrative opportunities to the key players during the forecast period, due to increase in adoption of pharmaceutical continuous manufacturing systems along with rise in presence of key pharmaceutical companies in Asia-Pacific.

Author Name(s) : Sagar Mukhekar | Roshan Deshmukh

Loading Table Of Content...

Individual sections of the reports are available for purchase.
Would you like to see a breakdown of prices by section?

Pharmaceutical Continuous Manufacturing Market

Global Opportunity Analysis and Industry Forecast, 2019-2026